PDSB
PDS Biotechnology Corp
0.7485$
+6.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.4% | 99.4% | 99.5% | 99.4% | 99.4% | 99.3% | 90.3% | 83.1% | 80.4% | 92.7% | 92.8% | 80.0% | |
| 94.9% | 95.2% | 96.6% | 95.4% | 94.9% | 91.9% | 85.0% | 78.7% | 75.5% | 87.6% | 87.8% | 63.5% | |
| 94.9% | 95.2% | 96.6% | 95.4% | 94.9% | 91.9% | 85.0% | 78.7% | 75.5% | 87.6% | 87.8% | 63.5% | |
| 57.2% | 56.0% | 46.1% | 48.9% | 58.1% | 58.1% | 52.4% | 60.6% | 72.8% | 69.7% | 84.2% | 140.6% | |
| 16.0% | 22.9% | 21.8% | 25.9% | 35.0% | 37.7% | 38.8% | 28.5% | 38.4% | 31.1% | 41.1% | 140.5% | |
| 0.1% | 7.1% | 10.6% | 17.3% | 23.9% | 27.7% | 26.7% | 13.7% | 17.4% | 16.9% | 21.2% | 49.4% | |
| 9.4% | 11.8% | 8.7% | 5.4% | 2.5% | 3.7% | 6.1% | 11.1% | 14.9% | 11.7% | 14.8% | 72.6% | |
| 40.9% | 32.8% | 24.1% | 22.8% | 22.9% | 20.3% | 13.5% | 32.0% | 34.3% | 38.5% | 43.0% | – | |
| 42.8% | 44.0% | 53.9% | 51.1% | 41.9% | 41.9% | 47.6% | 39.4% | 27.2% | 30.3% | 15.8% | -40.6% | |
| -233.6% | -243.3% | -224.8% | -270.2% | -332.0% | -401.5% | -405.3% | -494.2% | -602.3% | -710.3% | -908.1% | -2,653.6% | |
| 54.1% | 53.3% | 50.5% | 60.7% | 70.2% | 80.4% | 86.2% | 113.4% | 135.0% | 152.1% | 225.0% | 632.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.